Project: Development of microfluidics cartridge for next-generation point-of-care devices

We will develop the next generation platform for point of care (POC) diagnostics. BluSense is developing SenseLab, a POC device for high sensitivity immunoassays employing a novel detection technology. The business model is based on selling single use cartridges, which will be developed in this project. The consortium has in depth knowledge about development and large scale production of microfluidic consumables. We will deliver a simple to use, low cost cartridge for Diabetes type 2 monitoring.

Acronym DIADEM (Reference Number: 9858)
Duration 01/07/2015 - 01/04/2017
Project Topic Biological Sciences / Technologies
Network Eurostars 2
Call Eurostars Cut-Off 3

Project partner

Number Name Role Country
22092 Axxicon Moulds Eindhoven B.V. Partner Netherlands
22093 Micronit Microfluidics BV Partner Netherlands
22094 BluSense Diagnostics IVS Coordinator Denmark